11.87 USD
↘ 0.88 (6.90%)AT CLOSE (11:59 AM EDT)
MiNK Therapeutics, Inc. Common Stock
INKTNASDAQ • USD
11.23
↘ 0.64 (5.39%)
POST MARKET (AS OF 07:54 PM EDT)
Post Market
AS OF 07:54 PM EDT
11.23
↘ 0.64 (5.39%)
Market: CLOSED
Open?$12.66
High?$12.89
Low?$11.49
Prev. Close?$12.75
Volume?51.9K
Avg. Volume?38.5K
VWAP?$12.27
Rel. Volume?1.35x
Bid / Ask
Bid?$9.96 × 100
Ask?$14.82 × 100
Spread?$4.86
Midpoint?$12.39
Valuation & Ratios
Market Cap?59.1M
Shares Out?5.0M
Float?1.2M
Float %?24.8%
P/E Ratio?N/A
P/B Ratio?-4.66
EPS?-$2.50
Dividend?0.00%
Ex-Dividend?N/A
MiNK Therapeutics, Inc. Common Stock (INKT) trades at $11.87 per share. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (98.3%) and a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Jun 5, 2026.
RelatedFTFT
News
Profile
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.
Themes
Employees
15
Market Cap
59.1M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-10-15
Address
149 FIFTH AVENUE
NEW YORK, NY 10010
Phone: 212-994-8250
NEW YORK, NY 10010
Phone: 212-994-8250
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?30
Piotroski F-Score?0/9Weak
Altman Z-Score?-23.73Distress
Confidence?51%Low
Short InterestHigh
Short % of Float?10.56%High
Short Interest?123.0K
Days to Cover?4.4
Free Float1.2M
Avg Daily Volume27.7K
Settlement Date2026-05-15
Financial Health
Current Ratio?1.38Adequate
Quick Ratio?1.38Adequate
Cash Ratio?1.31Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-4.66CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-3.9CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?98.3%STRONG▾
S&P97
ROA?-120.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$49.6M
Fundamentals ratios updated end of day